Concepedia

TLR4 deficiency has a protective effect in the MPTP/probenecid mouse model of Parkinson’s disease

Qian-Hang Shao, Ying Chen, Fangfang Li, Shuo Wang, Xiaoling Zhang, Yu‐He Yuan, Nai‐Hong Chen

Acta Pharmacologica Sinica · 2019 · 82 citations · 23 references

DOIFull text

Open access

Concepts

References

23

In vivo demonstration that α-synuclein oligomers are toxic

Beate Winner, Roberto Jappelli, Samir K. Maji et al. · Proceedings of the National Academy of Sciences · 2011 · 1.5K citations · Full text

, , +17

Protocol for the MPTP mouse model of Parkinson's disease

Vernice Jackson‐Lewis, Serge Przedborski · Nature Protocols · 2007 · 1.1K citations

, , +12

Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway

Seija Lehnardt, Leon J. Massillon, Pamela L. Follett et al. · Proceedings of the National Academy of Sciences · 2003 · 1.1K citations · Full text

, , +17

Mouse model of Parkinsonism: a comparison between subacute MPTP and chronic MPTP/probenecid treatment

Elizabeth Petroske, G.E. Meredith, Shannon Callen et al. · Neuroscience · 2001 · 328 citations

, , +16

The interleukin 1 alpha, interleukin 1 beta, interleukin 6 and alpha-2-macroglobulin serum levels in patients with early or late onset Alzheimer's disease, mild cognitive impairment or Parkinson's disease

Erdinç Dursun, Duygu Gezen‐Ak, Haşmet Hanağası et al. · Journal of Neuroimmunology · 2015 · 230 citations

, , +17